WASHINGTON — A leading House Democrat is announcing a sweeping investigation of the pharmaceutical industry’s pricing practices. Oversight and Reform Committee Chairman Elijah Cummings said Monday that he’s sent letters to 12 major drug manufacturers seeking detailed information and documents about pricing practices for brand-name drugs to treat diseases including cancer, diabetes, kidney failure and
